Same Indication

Metformin vs Nivolumab

Metformin vs Nivolumab: Overview

This comparison examines the pharmacological differences between Metformin and Nivolumab.

Mechanism of Action

Metformin: Activates AMP-activated protein kinase, decreasing hepatic glucose production.

Nivolumab: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.

Pharmacokinetics

Half-life: Metformin — 4-9 hours; Nivolumab — 27 days.

Chemical Properties

Molecular Formula: Metformin — C4H11N5.

Molecular Weight: Metformin — 129.1640 g/mol.

Type: Metformin — Small molecule; Nivolumab — Antibody.